ROCHESTER, Mich., Oct. 19, 2022 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a number one supplier of point-of-care know-how options serving to sufferers begin and keep on remedy, will maintain a convention name on Tuesday, November 8, 2022, at 4:30 p.m. Eastern time to debate its outcomes for the third quarter, ended September 30, 2022. The monetary outcomes shall be issued in a press launch previous to the decision.
OptimizeRx administration will host the decision, adopted by a question-and-answer interval. Details for the convention name could be discovered beneath:
Please name the convention phone quantity or go surfing to the net entry hyperlink 5 minutes previous to the beginning time.
A replay of the decision will stay out there for 12 months through the Investors part of the OptimizeRx web site at www.optimizerx.com/buyers.
About OptimizeRx
OptimizeRx offers best-in-class well being know-how that permits care-focused engagement between life sciences organizations, healthcare suppliers, and sufferers at vital junctures all through the affected person care journey. Connecting over 60% of U.S. healthcare suppliers and hundreds of thousands of their sufferers via essentially the most clever know-how platform embedded inside a proprietary digital point-of-care community, OptimizeRx helps sufferers begin and keep on their medicines.
For extra data, comply with the Company on Twitter, LinkedIn or go to www.optimizerx.com.
Important Cautions Regarding Forward-Looking Statements
This press launch incorporates forward-looking statements inside the which means of the Private Securities Litigation Reform Act of 1995. Words comparable to “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or different related phrases and expressions are meant to determine these forward-looking statements. All statements that replicate the Company’s expectations, assumptions, projections, beliefs, or opinions concerning the future, apart from statements of historic reality, are forward-looking statements, together with, with out limitation, statements referring to the Company’s progress, business plans, and future efficiency. These forward-looking statements are primarily based on the Company’s present expectations and assumptions concerning the Company’s business, the economy, and different future circumstances. The Company disclaims any intention or obligation to publicly replace or revise any forward-looking statements, whether or not due to new data, future occasions, or in any other case, besides as required by relevant regulation. Forward-looking statements are inherently topic to dangers and uncertainties, a few of which can’t be predicted or quantified. Future occasions and precise outcomes might differ materially from these set forth in, contemplated by, or underlying the forward-looking statements. The dangers and uncertainties to which forward-looking statements are topic embody, however aren’t restricted to, the impact of presidency regulation, competitors, and different dangers summarized within the Company’s Annual Report on Form 10-Okay for the fiscal 12 months ended December 31, 2021, its subsequent Quarterly Reports on Form 10-Q, and its different filings with the Securities and Exchange Commission.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
[email protected]
Media Relations Contact
Kimberley Sirk, Media Relations Manager
[email protected]
Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
[email protected]
